Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014, Article ID 698758, 4 pages
http://dx.doi.org/10.1155/2014/698758
Case Report

Efficient and Cost-Effective Alternative Treatment for Recurrent Urinary Tract Infections and Interstitial Cystitis in Women: A Two-Case Report

1School of Medicine, Lebanese American University, Byblos 1401, Lebanon
2School of Pharmacy, Lebanese American University, Byblos 1401, Lebanon
3Clinic Dr. Ralph Irani for Alternative Medicine, Beirut 1202, Lebanon
4Pharmaceutical Science Department, School of Pharmacy, Lebanese American University, Byblos 1401, Lebanon

Received 25 October 2014; Accepted 28 November 2014; Published 21 December 2014

Academic Editor: Ludger Klimek

Copyright © 2014 Anthony Mansour et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Foxman, “The epidemiology of urinary tract infection,” Nature Reviews Urology, vol. 7, no. 12, pp. 653–660, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Foxman and P. Brown, “Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs,” Infectious Disease Clinics of North America, vol. 17, no. 2, pp. 227–241, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Foxman, B. Gillespie, J. Koopman et al., “Risk factors for second urinary tract infection among college women,” American Journal of Epidemiology, vol. 151, no. 12, pp. 1194–1205, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. T. M. Hooton, “Uncomplicated urinary tract infection,” The New England Journal of Medicine, vol. 366, no. 11, pp. 1028–1037, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. J. Dielubanza and A. J. Schaeffer, “Urinary tract infections in women,” Medical Clinics of North America, vol. 95, no. 1, pp. 27–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. E. Barber, J. P. Norton, A. M. Spivak, and M. A. Mulvey, “Urinary tract infections: current and emerging management strategies,” Clinical Infectious Diseases, vol. 57, no. 5, pp. 719–724, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Kodner and E. K. Thomas Gupton, “Recurrent urinary tract infections in women: diagnosis and management,” American Family Physician, vol. 82, no. 6, pp. 638–643, 2010. View at Google Scholar · View at Scopus
  8. B. Foxman, M. Ki, and P. Brown, “Antibiotic resistance and pyelonephritis,” Clinical Infectious Diseases, vol. 45, no. 3, pp. 281–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Gupta, T. M. Hooton, K. G. Naber et al., “International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the infectious diseases society of America and the European Society for Microbiology and Infectious Diseases,” Clinical Infectious Diseases, vol. 52, no. 5, pp. e103–e120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Foxman and M. Buxton, “Alternative approaches to conventional treatment of acute uncomplicated urinary tract infection in women,” Current Infectious Disease Reports, vol. 15, no. 2, pp. 124–129, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. R. T. Foster Sr., “Uncomplicated urinary tract infections in women,” Obstetrics and Gynecology Clinics of North America, vol. 35, no. 2, pp. 235–248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. USFDA, “FDA Drug Safety Communication: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection,” 2013, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM365078.pdf.
  13. J. D. D. Pitout, “Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment,” Expert Review of Anti-Infective Therapy, vol. 10, no. 10, pp. 1165–1176, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. J. Lee, K. H. Son, H. W. Chang et al., “Antiinflammatory activity of naturally occurring flavone and flavonol glycosides,” Archives of Pharmacal Research, vol. 16, no. 1, pp. 25–28, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. S. I. Kreydiyyeh and J. Usta, “Diuretic effect and mechanism of action of parsley,” Journal of Ethnopharmacology, vol. 79, no. 3, pp. 353–357, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. N. D. Weber, D. O. Andersen, J. A. North, B. K. Murray, L. D. Lawson, and B. G. Hughes, “In vitro virucidal effects of Allium sativum (garlic) extract and compounds,” Planta Medica, vol. 58, no. 5, pp. 417–423, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ankri and D. Mirelman, “Antimicrobial properties of allicin from garlic,” Microbes and Infection, vol. 1, no. 2, pp. 125–129, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. R. S. Feldberg, S. C. Chang, A. N. Kotik et al., “In vitro mechanism of inhibition of bacterial cell growth by allicin,” Antimicrobial Agents and Chemotherapy, vol. 32, no. 12, pp. 1763–1768, 1988. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Harjai, R. Kumar, and S. Singh, “Garlic blocks quorum sensing and attenuates the virulence of Pseudomonas aeruginosa,” FEMS Immunology and Medical Microbiology, vol. 58, no. 2, pp. 161–168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Hagberg, U. Jodal, T. K. Korhonen, G. Lidin-Janson, U. Lindberg, and C. Svanborg Edén, “Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections,” Infection and Immunity, vol. 31, no. 2, pp. 564–570, 1981. View at Google Scholar · View at Scopus
  21. T. Kontiokari, K. Sundqvist, M. Nuutinen, T. Pokka, M. Koskela, and M. Uhari, “Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women,” British Medical Journal, vol. 322, no. 7302, pp. 1571–1573, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. S. J. Eells, K. Bharadwa, J. A. McKinnell, and L. G. Miller, “Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a markov chain monte carlo model,” Clinical Infectious Diseases, vol. 58, no. 2, pp. 147–160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Xie, B. Foxman, L. Zhang, and C. F. Marrs, “Molecular epidemiologic identification of Escherichia coli genes that are potentially involved in movement of the organism from the intestinal tract to the vagina and bladder,” Journal of Clinical Microbiology, vol. 44, no. 7, pp. 2434–2441, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Karlsson, N. Scherbak, H. Khalaf, P.-E. Olsson, and J. Jass, “Substances released from probiotic Lactobacillus rhamnosus GR-1 potentiate NF-κB activity in Escherichia coli-stimulated urinary bladder cells,” FEMS Immunology and Medical Microbiology, vol. 66, no. 2, pp. 147–156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. J. Beerepoot, G. T. Riet, S. Nys et al., “Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women,” Archives of Internal Medicine, vol. 172, no. 9, pp. 704–712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Reid, D. Beuerman, C. Heinemann, and A. W. Bruce, “Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora,” FEMS Immunology and Medical Microbiology, vol. 32, no. 1, pp. 37–41, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Morelli, D. Zonenenschain, M. Del Piano, and P. Cognein, “Utilization of the intestinal tract as a delivery system for urogenital probiotics,” Journal of clinical gastroenterology, vol. 38, no. 6, pp. S107–S110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Reid, D. Charbonneau, J. Erb et al., “Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women,” FEMS Immunology and Medical Microbiology, vol. 35, no. 2, pp. 131–134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Reid, A. W. Bruce, N. Fraser, C. Heinemann, J. Owen, and B. Henning, “Oral probiotics can resolve urogenital infections,” FEMS Immunology and Medical Microbiology, vol. 30, no. 1, pp. 49–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. R. M. J. Palmer, A. G. Ferrige, and S. Moncada, “Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor,” Nature, vol. 327, no. 6122, pp. 524–526, 1987. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991. View at Google Scholar · View at Scopus